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Porcine Coronary Artery In Endothelium-Independent Pathway 
Sophie YW Kwan, Susan WS Leung, Ricky YK Man 
The University of Hong Kong, Hong Kong, Hong Kong 
Background: Exchange protein directly activated by cyclic AMP (cAMP) 1, Epac1, is a newly 
discovered cAMP target which acts beyond the classical cAMP effector protein kinase A (PKA). The 
identification of Epac1 overthrows the concept that cAMP activatez single effector. Epac1 is a guanine 
nucleotide exchange factor (GEF) probably activates small G-protein Rap1. Epac1 ubiquitously 
expresses in all tissues and therefore should play important roles in cellular signaling. Appreciation of 
the potential importance of Epac1 has come with the current development of Epac1-selective-cAMP 
analogs for discriminating the activation from PKA to Epac1. Among those analogs, 8-pCPT-2'-O-Me-
cAMP (8-pCPT) is the most potent Epac1 activator available (Kd=2.2 µM) with a low affinity to PKA 
(Kd=200-300 µM). 8-pCPT was revealed to induce aorta and airway relaxation, whereas the underlying 
mechanism remains unclear. Moreover, to date no comparable data exist on the role of Epac1 in 
porcine vascular system. Current study aimed to investigate the effect of 8-pCPT in isolated porcine 
coronary vasodilatation. 
Methods: Hearts from either sexes of pig (50-70kg) were collected from local slaughter house right 
before experiment. Right coronary arteries were isolated and the surrounding connective tissue was 
removed before being cut into 2-3mm rings. For endothelium-independent experiments, the 
endothelial layer was removed mechanically. Rings were mounted on organ chamber and immersed 
in physiological solution (Krebs-Henseleit, 37oC, 5%O2). Change in isometric tension was recorded 
with the basal tension being adjusted to 2g. Indomethacin (COX1-inhibtior, 10 µM, EtOH) and 
SQ22536 (adenylyl cyclase inhibitor, 100 µM, H2O) were added to all chambers for 30 minutes to 
eliminate COX derivatives and endogenous cAMP respectively. Rings were then challenged with 
thromboxane A2 analogue U46619 (30 nM, MeOAc) and direct relaxation was examined by 
cumulative addition of 8-pCPT (10 nM- 100 µM, H2O) in the presence of different blockers. 8-pCPT 
was also used to incubate with rings prior to the contraction-relaxation responds induced by 
cumulative addition of forskolin (adenylyl cyclase activator), 6-MB (selective PKA activator) or 
levcromakalim (KATP channel opener) to investigate the potentiated effect of Epac1. Data is presented 
in % of relaxation with 30 nM U46619 contraction. U46619 was also used to construct cumulative 
dose-respond contraction curve in the presence or absent of 8-pCPT. Data is presented in %of 
contraction to 60mM KCl contraction. In addition the artery rings underwent protein extraction for 
immunoblotting against anti-Epac1 antibody (Epac (A-5)), rat aortae (12-weeks male Sprague-Dawley 
(SD)) were used as control. 
Results: Epac (A-5) antibody detected one discrete protein band ~99kDa in porcine coronary artery 
smooth muscle extraction. Up to 100 µM 8-pCPT counteract U46619 contraction in rings with 
endothelium (-89.7%±8.7, n=5) and without endothelium (-95.6%±13.6, n=5) which the half-maximal 
concentration is 37.8 µM (±12.5). Hence all the rings in the following experiments were endothelium-
removed for us to focus on the effect in smooth muscle layer. However incubation of BFA (Rap/GEF 
fixer, 30 µM, DMSO) and GGTI-298 (Rap1 inhibitor, 10 µM, DMSO) did not reverse 8-pCPT induced 
relaxation (n=1-3). Also GGTI-298 showed no effect on forskolin-induced, PKA independent (with Rp-
8-Br-cAMPS (PKA inhibitor, 100 µM, H2O)) vasodilation (10 nM-10 µM) (n=3). Also 8-pCPT (100 nM- 
30 µM) did not alter 6-MB (10 µM- 1 mM, H2O) (n=3) or levcromakalim (10 nM- 10 µM, DMSO) (n=7) -
induced vasodilation. Nevertheless, 8-pCPT (30 µM) significantly reduced the maximal contraction to 
U46619 (1 nM- 1µM) by 19.7% (±6.6, n=6, P<0.01) while the same inhibition do not occur under the 
incubation with Y27632 (Rho-kinase inhibitor, 10 µM, H2O) 
Summary: The results obtained suggested that Epac1 induces direct relaxation in porcine coronary 
artery via endothelium-independent pathway whereas does not undergo Rap1. Though theoretically 
we cannot exclude that Eapc1 activates Rap1 in porcine coronary artery but it is less possible that 
Rap1 participates in smooth relaxation. Although reports suggested that Epac1 modulate PKA or KATP 
channels activity, we did not observed such relationship in porcine coronary artery smooth muscle. 
Interestingly Epac1 modulate RhoA/Rho-kinase dependent smooth muscle contraction, suggested that 
RhoA/Rho-kinase is one of the possible targets of Epac1. Beyond the above findings, the complete 
mechanism of Epac1-induced vasodilation is still unclear, it is room for determination of the 
unrecognized role of other proposed downstream effectors of Epac1 such as Rac, Rap2b, AMPK and 
Akt, in the action of vasodilation in porcine coronary artery. 
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